Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Cell Stem Cell
|
April 16, 2019
Spatially Restricted Stromal Wnt Signaling Restrains Prostate Epithelial Progenitor Growth through Direct and Indirect Mechanisms
Xing Wei, Li Zhang, Zhicheng Zhou, et al.
Prostate Cancer and Prostatic Diseases
|
March 21, 2019
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy
Mazen Alsinnawi, Ailin Zhang, Daniella Bianchi-Frias, et al.
Nature Communications
|
November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity
Deyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
The Journal of Pathology
|
February 27, 2022
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies
Joanna Cyrta, Davide Prandi, Arshi Arora, et al.
Molecular Cancer Research : MCR
|
January 13, 2016
Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations
Daniella Bianchi-Frias, Ryan Basom, Jeffrey J Delrow, et al.
Cancer Research
|
May 10, 2017
TWIST1-WDR5-<i>Hottip</i> Regulates <i>Hoxa9</i> Chromatin to Facilitate Prostate Cancer Metastasis
Reem Malek, Rajendra P Gajula, Russell D Williams, et al.
Virchows Archiv : an International Journal of Pathology
|
October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
Rodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Pathology
|
December 5, 2014
Active surveillance for prostate cancer: the role of the pathologist
Brett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Cell
|
July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Qianben Wang, Wei Li, Yong Zhang, et al.
Archives of Pathology & Laboratory Medicine
|
August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation
Mahul B Amin, Daniel W Lin, John L Gore, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Cell Stem Cell
|
April 16, 2019
Spatially Restricted Stromal Wnt Signaling Restrains Prostate Epithelial Progenitor Growth through Direct and Indirect Mechanisms
Xing Wei, Li Zhang, Zhicheng Zhou, et al.
Prostate Cancer and Prostatic Diseases
|
March 21, 2019
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy
Mazen Alsinnawi, Ailin Zhang, Daniella Bianchi-Frias, et al.
Nature Communications
|
November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity
Deyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
The Journal of Pathology
|
February 27, 2022
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies
Joanna Cyrta, Davide Prandi, Arshi Arora, et al.
Molecular Cancer Research : MCR
|
January 13, 2016
Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations
Daniella Bianchi-Frias, Ryan Basom, Jeffrey J Delrow, et al.
Cancer Research
|
May 10, 2017
TWIST1-WDR5-<i>Hottip</i> Regulates <i>Hoxa9</i> Chromatin to Facilitate Prostate Cancer Metastasis
Reem Malek, Rajendra P Gajula, Russell D Williams, et al.
Virchows Archiv : an International Journal of Pathology
|
October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
Rodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Pathology
|
December 5, 2014
Active surveillance for prostate cancer: the role of the pathologist
Brett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Cell
|
July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Qianben Wang, Wei Li, Yong Zhang, et al.
Archives of Pathology & Laboratory Medicine
|
August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation
Mahul B Amin, Daniel W Lin, John L Gore, et al.
Page
of 6